Curcumin suppresses constitutive activation of STAT-3 by up-regulating protein inhibitor of activated STAT-3 (PIAS-3) in ovarian and endometrial cancer cells - PubMed (original) (raw)
. 2010 May 15;110(2):447-56.
doi: 10.1002/jcb.22558.
Affiliations
- PMID: 20235152
- DOI: 10.1002/jcb.22558
Curcumin suppresses constitutive activation of STAT-3 by up-regulating protein inhibitor of activated STAT-3 (PIAS-3) in ovarian and endometrial cancer cells
Manush Saydmohammed et al. J Cell Biochem. 2010.
Abstract
Signal transducer and activator of transcription-3 (STAT-3) is constitutively activated in ovarian and endometrial cancers and is implicated in uncontrolled cell growth. Thus, its disruption could be an effective approach to control tumorigenesis. Curcumin is a dihydroxyphenolic compound, with proven anti-cancer efficacy in various cancer models. We examined the anti-tumor mechanism of curcumin on STAT-3 and on the negative regulators of STAT-3, including suppressors of cytokine signaling proteins (SOCS-1 and SOCS-3), protein inhibitors of activated STAT (PIAS-1 and PIAS-3), and SH2 domain-containing phosphatases (SHP-1 and SHP-2) in ovarian and endometrial cancer cell lines. Treatment of cancer cells with curcumin induced a dose- and time-dependent decrease of constitutive IL-6 expression and of constitutive and IL-6-induced STAT-3 phosphorylation, which is associated with decreased cell viability and increased cleavage of caspase-3. The inhibition of STAT-3 activation by curcumin was reversible, and phosphorylated STAT-3 levels returned to control levels 24 h after curcumin removal. Compared to normal cells baseline expression of SOCS-3 was high in cancer cells and a marked decrease in SOCS-3 expression was seen following curcumin treatment. Overexpression of SOCS-3 in curcumin-treated cells increased expression of phosphorylated STAT-3 and resulted in increased cell viability. Normal ovarian and endometrial cells exhibited high expression of PIAS-3 protein, whereas in cancer cells the expression was greatly reduced. Curcumin increased PIAS-3 expression in cancer cells. Of significance, siRNA-mediated knockdown of PIAS-3 overcomes the inhibitory effect of curcumin on STAT-3 phosphorylation and cell viability. In conclusion, curcumin suppresses JAK-STAT signaling via activation of PIAS-3, thus attenuating STAT-3 phosphorylation and tumor cell growth.
(c) 2010 Wiley-Liss, Inc.
Similar articles
- Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer.
Duan Z, Foster R, Bell DA, Mahoney J, Wolak K, Vaidya A, Hampel C, Lee H, Seiden MV. Duan Z, et al. Clin Cancer Res. 2006 Sep 1;12(17):5055-63. doi: 10.1158/1078-0432.CCR-06-0861. Clin Cancer Res. 2006. PMID: 16951221 - Brassinin inhibits STAT3 signaling pathway through modulation of PIAS-3 and SOCS-3 expression and sensitizes human lung cancer xenograft in nude mice to paclitaxel.
Lee JH, Kim C, Sethi G, Ahn KS. Lee JH, et al. Oncotarget. 2015 Mar 20;6(8):6386-405. doi: 10.18632/oncotarget.3443. Oncotarget. 2015. PMID: 25788267 Free PMC article. - Targeting Oncogenic Transcription Factors: Therapeutic Implications of Endogenous STAT Inhibitors.
Heppler LN, Frank DA. Heppler LN, et al. Trends Cancer. 2017 Dec;3(12):816-827. doi: 10.1016/j.trecan.2017.10.004. Epub 2017 Nov 10. Trends Cancer. 2017. PMID: 29198438 Free PMC article. Review. - Negative regulators of STAT3 signaling pathway in cancers.
Wu M, Song D, Li H, Yang Y, Ma X, Deng S, Ren C, Shu X. Wu M, et al. Cancer Manag Res. 2019 May 29;11:4957-4969. doi: 10.2147/CMAR.S206175. eCollection 2019. Cancer Manag Res. 2019. PMID: 31213912 Free PMC article. Review.
Cited by
- Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice.
Sun J, Zhao Y, Hu J. Sun J, et al. PLoS One. 2013 Jun 25;8(6):e67078. doi: 10.1371/journal.pone.0067078. Print 2013. PLoS One. 2013. PMID: 23825622 Free PMC article. - Protein Inhibitor of Activated STAT3 (PIAS3) Is Down-Regulated in Eutopic Endometrium of Women with Endometriosis.
Yoo JY, Jeong JW, Fazleabas AT, Tayade C, Young SL, Lessey BA. Yoo JY, et al. Biol Reprod. 2016 Jul;95(1):11. doi: 10.1095/biolreprod.115.137158. Epub 2016 May 25. Biol Reprod. 2016. PMID: 27226311 Free PMC article. - Molecular targets of curcumin for cancer therapy: an updated review.
Kasi PD, Tamilselvam R, Skalicka-Woźniak K, Nabavi SF, Daglia M, Bishayee A, Pazoki-Toroudi H, Nabavi SM. Kasi PD, et al. Tumour Biol. 2016 Oct;37(10):13017-13028. doi: 10.1007/s13277-016-5183-y. Epub 2016 Jul 28. Tumour Biol. 2016. PMID: 27468716 Review. - Interleukin 13 promotes long-term recovery after ischemic stroke by inhibiting the activation of STAT3.
Chen D, Li J, Huang Y, Wei P, Miao W, Yang Y, Gao Y. Chen D, et al. J Neuroinflammation. 2022 May 16;19(1):112. doi: 10.1186/s12974-022-02471-5. J Neuroinflammation. 2022. PMID: 35578342 Free PMC article. - Small molecule targeted therapies for endometrial cancer: progress, challenges, and opportunities.
Yang FF, Zhao TT, Milaneh S, Zhang C, Xiang DJ, Wang WL. Yang FF, et al. RSC Med Chem. 2024 Apr 11;15(6):1828-1848. doi: 10.1039/d4md00089g. eCollection 2024 Jun 19. RSC Med Chem. 2024. PMID: 38911148 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous